Literature DB >> 23458260

Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search.

Ariane Wohlfarth1, Karl B Scheidweiler, Xiaohong Chen, Hua-fen Liu, Marilyn A Huestis.   

Abstract

INTRODUCTION: Synthetic cannabinoids are an emerging illicit drug class. The variety of available substances is large and ever-changing, making it difficult for laboratories to remain current. We present a qualitative LC-MS/MS method identifying urinary metabolites of JWH-018, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-250, RCS-4, and AM2201 and the parent compounds JWH-018, JWH-073, JWH-081, JWH-122, JWH-210, JWH-250, RCS-4, AM2201, and MAM2201.
METHODS: After enzymatic hydrolysis, urinary proteins were precipitated with acetonitrile. Chromatography utilized a 10 min gradient on a Kinetex XB-C18 column with 0.1% formic acid in water and acetonitrile. Scheduled multiple reaction monitoring "survey scans" were followed by information-dependent acquisition-enhanced product ion scan experiments on an ABSciex 5500 QTRAP mass spectrometer. Analytes were identified by software-assisted library searching against reference spectra.
RESULTS: The method was fully validated, including proof of selectivity (no exogenous or endogenous interferences were observed), assessment of matrix effects (95-122%) and recovery (53-95%), determination of limits of detection (0.5-10 ng/mL), carry-over studies (thresholds between 100 and 1000 ng/mL), and determination of autosampler stability (samples were stable for at least 3 days). Hydrolysis efficiency was thoroughly investigated for a wide range of glucuronides and for the reference standard, JWH-018 5-hydroxypentyl glucuronide.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458260      PMCID: PMC3874406          DOI: 10.1021/ac3037365

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

1.  Creation and comparison of MS/MS spectral libraries using quadrupole ion trap and triple-quadrupole mass spectrometers.

Authors:  Jonathan L Josephs; Mark Sanders
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

2.  Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens.

Authors:  Hsiu-Chuan Liu; Ray H Liu; Hsiu-O Ho; Dong-Liang Lin
Journal:  Anal Chem       Date:  2009-11-01       Impact factor: 6.986

3.  Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.

Authors:  Andrej Grigoryev; Sergey Savchuk; Aleksandra Melnik; Natal'ja Moskaleva; Jurij Dzhurko; Mihail Ershov; Aleksandr Nosyrev; Aleksandr Vedenin; Boris Izotov; Irina Zabirova; Vladimir Rozhanets
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-26       Impact factor: 3.205

4.  Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

Authors:  Krishna C Chimalakonda; Cindy L Moran; Paul D Kennedy; Gregory W Endres; Adam Uzieblo; Paul J Dobrowolski; E Kim Fifer; Jeff Lapoint; Lewis S Nelson; Robert S Hoffman; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-07-27       Impact factor: 6.986

5.  Detection of JWH-018 metabolites in smoking mixture post-administration urine.

Authors:  Tim Sobolevsky; Ilya Prasolov; Grigory Rodchenkov
Journal:  Forensic Sci Int       Date:  2010-04-28       Impact factor: 2.395

6.  The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry.

Authors:  Andrej Grigoryev; Pierce Kavanagh; Aleksandra Melnik
Journal:  Drug Test Anal       Date:  2011-11-18       Impact factor: 3.345

7.  Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

Authors:  Cindy L Moran; Vi-Huyen Le; Krishna C Chimalakonda; Amy L Smedley; Felisia D Lackey; Suzanne N Owen; Paul D Kennedy; Gregory W Endres; Fred L Ciske; James B Kramer; Andrei M Kornilov; L D Bratton; Paul J Dobrowolski; William D Wessinger; William E Fantegrossi; Paul L Prather; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-05-06       Impact factor: 6.986

8.  Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.

Authors:  Tsadik T Abraham; Ross H Lowe; Stephane O Pirnay; William D Darwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-10       Impact factor: 3.367

9.  Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.

Authors:  P M Kemp; I K Abukhalaf; J E Manno; B R Manno; D D Alford; M E McWilliams; F E Nixon; M J Fitzgerald; R R Reeves; M J Wood
Journal:  J Anal Toxicol       Date:  1995-09       Impact factor: 3.367

10.  The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry.

Authors:  Pierce Kavanagh; Andrej Grigoryev; Aleksandra Melnik; Anton Simonov
Journal:  J Anal Toxicol       Date:  2012-06       Impact factor: 3.367

View more
  17 in total

1.  CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Hippocampus       Date:  2014-02       Impact factor: 3.899

Review 2.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

3.  Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.

Authors:  Qiang Ma; Hua Bai; Wentao Li; Chao Wang; R Graham Cooks; Zheng Ouyang
Journal:  Talanta       Date:  2015-04-24       Impact factor: 6.057

4.  Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine.

Authors:  Allan J Barnes; Sheena Young; Eliani Spinelli; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2014-04-24       Impact factor: 2.395

5.  Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.

Authors:  Adarsh S Gandhi; Mingshe Zhu; Shaokun Pang; Ariane Wohlfarth; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Bioanalysis       Date:  2014-06       Impact factor: 2.681

6.  Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2013-12-30       Impact factor: 4.759

7.  Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.

Authors:  Marisol S Castaneto; Karl B Scheidweiler; Adarsh Gandhi; Ariane Wohlfarth; Kevin L Klette; Thomas M Martin; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-09-17       Impact factor: 3.345

8.  Validation of an ELISA Synthetic Cannabinoids Urine Assay.

Authors:  Allan J Barnes; Eliani Spinelli; Sheena Young; Thomas M Martin; Kevin L Kleete; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2015-10       Impact factor: 3.681

9.  Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Jeremy Carlier; Karl B Scheidweiler; Ariane Wohlfarth; Bonita D Salmeron; Michael H Baumann; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-06       Impact factor: 4.759

10.  First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry.

Authors:  Adarsh S Gandhi; Mingshe Zhu; Shaokun Pang; Ariane Wohlfarth; Karl B Scheidweiler; Hua-Fen Liu; Marilyn A Huestis
Journal:  AAPS J       Date:  2013-08-03       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.